Switch theme
Sign up to access all valuation multiples
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
2007
1.2K+
LTM Revenue $863M
LTM EBITDA $169M
$3.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Inspire Medical Systems has a last 12-month revenue (LTM) of $863M and a last 12-month EBITDA of $169M.
In the most recent fiscal year, Inspire Medical Systems achieved revenue of $803M and an EBITDA of $65.0M.
Inspire Medical Systems expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Inspire Medical Systems valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $863M | XXX | $803M | XXX | XXX | XXX |
| Gross Profit | $732M | XXX | $680M | XXX | XXX | XXX |
| Gross Margin | 85% | XXX | 85% | XXX | XXX | XXX |
| EBITDA | $169M | XXX | $65.0M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 8% | XXX | XXX | XXX |
| EBIT | $45.0M | XXX | $36.1M | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 4% | XXX | XXX | XXX |
| Net Profit | $60.4M | XXX | $53.5M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Inspire Medical Systems's stock price is $138.
Inspire Medical Systems has current market cap of $4.1B, and EV of $3.7B.
See Inspire Medical Systems trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.7B | $4.1B | XXX | XXX | XXX | XXX | $1.96 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Inspire Medical Systems has market cap of $4.1B and EV of $3.7B.
Inspire Medical Systems's trades at 4.7x EV/Revenue multiple, and 57.5x EV/EBITDA.
Equity research analysts estimate Inspire Medical Systems's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Inspire Medical Systems has a P/E ratio of 67.5x.
See valuation multiples for Inspire Medical Systems and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4.1B | XXX | $4.1B | XXX | XXX | XXX |
| EV (current) | $3.7B | XXX | $3.7B | XXX | XXX | XXX |
| EV/Revenue | 4.3x | XXX | 4.7x | XXX | XXX | XXX |
| EV/EBITDA | 22.2x | XXX | 57.5x | XXX | XXX | XXX |
| EV/EBIT | 83.0x | XXX | 103.7x | XXX | XXX | XXX |
| EV/Gross Profit | 5.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 67.5x | XXX | 76.2x | XXX | XXX | XXX |
| EV/FCF | 26.3x | XXX | 41.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialInspire Medical Systems's last 12 month revenue growth is 18%
Inspire Medical Systems's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.5M for the same period.
Inspire Medical Systems's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Inspire Medical Systems's rule of X is 64% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Inspire Medical Systems and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 18% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 32% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 15% | XXX | 26% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 64% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 80% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Inspire Medical Systems acquired XXX companies to date.
Last acquisition by Inspire Medical Systems was XXXXXXXX, XXXXX XXXXX XXXXXX . Inspire Medical Systems acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Inspire Medical Systems founded? | Inspire Medical Systems was founded in 2007. |
| Where is Inspire Medical Systems headquartered? | Inspire Medical Systems is headquartered in United States of America. |
| How many employees does Inspire Medical Systems have? | As of today, Inspire Medical Systems has 1.2K+ employees. |
| Who is the CEO of Inspire Medical Systems? | Inspire Medical Systems's CEO is Mr. Timothy P. Herbert. |
| Is Inspire Medical Systems publicy listed? | Yes, Inspire Medical Systems is a public company listed on NYS. |
| What is the stock symbol of Inspire Medical Systems? | Inspire Medical Systems trades under INSP ticker. |
| When did Inspire Medical Systems go public? | Inspire Medical Systems went public in 2018. |
| Who are competitors of Inspire Medical Systems? | Similar companies to Inspire Medical Systems include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Inspire Medical Systems? | Inspire Medical Systems's current market cap is $4.1B |
| What is the current revenue of Inspire Medical Systems? | Inspire Medical Systems's last 12 months revenue is $863M. |
| What is the current revenue growth of Inspire Medical Systems? | Inspire Medical Systems revenue growth (NTM/LTM) is 18%. |
| What is the current EV/Revenue multiple of Inspire Medical Systems? | Current revenue multiple of Inspire Medical Systems is 4.3x. |
| Is Inspire Medical Systems profitable? | Yes, Inspire Medical Systems is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Inspire Medical Systems? | Inspire Medical Systems's last 12 months EBITDA is $169M. |
| What is Inspire Medical Systems's EBITDA margin? | Inspire Medical Systems's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Inspire Medical Systems? | Current EBITDA multiple of Inspire Medical Systems is 22.2x. |
| What is the current FCF of Inspire Medical Systems? | Inspire Medical Systems's last 12 months FCF is $142M. |
| What is Inspire Medical Systems's FCF margin? | Inspire Medical Systems's last 12 months FCF margin is 16%. |
| What is the current EV/FCF multiple of Inspire Medical Systems? | Current FCF multiple of Inspire Medical Systems is 26.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
